Clinical Trial Update: A Study To Determine The Effect Of SB-480848 On Asthma [Phase 1]

View source ↗

Summary

A Phase 1 study by GlaxoSmithKline evaluating SB-480848 in asthma, with atherosclerosis listed as a condition, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atherosclerosis

Drugs mentioned

• SB-480848

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED